Digest Network How does it work
Network
/
Society
Ci
Not verified

Circle Pharma

What we write about

FinanceHealthMedicine - variousOncologyPharmaceuticals

7 Press releases

View all press releases
09/09/2025
Scienza
Associations / Professional
Pharmaceuticals
Oncology
Finance
Tecnica
Medicine - various
Biotechnology
Health
Labour market
Circle Pharma Announces Agreement with Lilly to Further Enhance AI/ML Capabilities and Accelerate Development of New Oral Macrocycle Therapies
Source
Circle Pharma
Issuer
Business Wire
1.00
0
12/05/2025
Eventi
Industria
Oncology
Associations / Professional
Health
Finance
Medicine - various
Pharmaceuticals
Biotechnology
Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting
Source
Circle Pharma
Issuer
Business Wire
1.00
0
22/04/2025
Eventi
Market analysis
Scienza
Finance
Biotechnology
Medicine - various
Associations / Professional
Pharmaceuticals
Health
Oncology
Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors
Source
Circle Pharma
Issuer
Business Wire
1.00
0
31/03/2025
Eventi
Oncology
Associations / Professional
Health
Finance
Medicine - various
Pharmaceuticals
Biotechnology
Circle Pharma to Present at the Upcoming Investor Conferences
Source
Circle Pharma
Issuer
Business Wire
1.00
0
09/12/2024
Scienza
Finance
Medicine - various
Associations / Professional
Biotechnology
Sanità
Pharmaceuticals
Health
Oncology
Eventi
Fairs
Industria
Circle Pharma Presents Promising Preclinical Data on First-in-Class Oral Macrocycle Cyclin A/B RxL Inhibitor CID-078 at the San Antonio Breast Cancer Symposium 2024
Source
Circle Pharma
Issuer
Business Wire
1.00
0
09/10/2024
Labour market
Industria
Scienza
Finance
Biotechnology
Medicine - various
Associations / Professional
Pharmaceuticals
Health
Oncology
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
Source
Circle Pharma
Issuer
Business Wire
1.00
0
01/07/2024
Industria
Scienza
Finance
Pharmaceuticals
Oncology
Health
Associations / Professional
Medicine - various
Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors
Source
Circle Pharma
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0